A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC
Clinical trial NCT03557411 · UNKNOWN
Trial details
- NCT number
- NCT03557411
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-09
- Primary completion
- 2020-07-09
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.